SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-22-032221
Filing Date
2022-11-14
Accepted
2022-11-14 17:03:58
Documents
6
Effectiveness Date
2022-11-14

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 85520
2 ex5-1.htm EX-5.1 9985
3 ex5-1_001.jpg GRAPHIC 8374
4 ex23-1.htm EX-23.1 3053
5 ex99-1.htm EX-99.1 60814
6 ex107.htm EX-FILING FEES 14070
  Complete submission text file 0001493152-22-032221.txt   186207
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-268353 | Film No.: 221387329
SIC: 2834 Pharmaceutical Preparations